Trials / Unknown
UnknownNCT05758675
Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023
Study on the Antibody Level Against SARS-CoV-2 in Dazhu County in 2023
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Sinocelltech Ltd. · Industry
- Sex
- All
- Age
- 3 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
About 15,000 to 25,000 subjects will be screened. Their information will be collected, venous blood will be sampled, their serum antibody levels will be detected, and the incidence of COVID-19 wil be followed up.
Detailed description
Data of the following will be collected: 1. Demographic data,including Name, Gender, Ethnic groups, ID Card number (age automatically calculated), Height/weight (automatic BMI calculation); 2. Previous disease/surgical history; 3. Previous COVID-19 infections; 4. COVID-19 vaccination history; 5. Infection after this screening; 6. Screening information for COVID-19 antibodies. Atibody level against SARS-CoV-2 will be test.
Conditions
Timeline
- Start date
- 2023-02-21
- Primary completion
- 2023-09-08
- Completion
- 2023-12-08
- First posted
- 2023-03-07
- Last updated
- 2023-03-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05758675. Inclusion in this directory is not an endorsement.